Journal article
Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis
Abstract
The role of maintenance therapy after high-dose chemotherapy and first autologous transplantation in multiple myeloma (MM) is well established. We explored the effect of maintenance therapy on outcomes after salvage second autologous hematopoietic cell transplant (AHCT2) using the Center for International Blood and Marrow Transplant Research registry. Outcomes of interest included non-relapse mortality (NRM), relapse/progression (REL), …
Authors
Pasvolsky O; Yeshurun M; Fraser R; Estrada-Merly N; Rozovski U; Shargian-Alon L; Assal A; Banerjee R; Bumma N; Gale RP
Journal
Bone Marrow Transplantation, Vol. 57, No. 1, pp. 31–37
Publisher
Springer Nature
Publication Date
January 2022
DOI
10.1038/s41409-021-01455-y
ISSN
0268-3369